| Literature DB >> 29124751 |
Teresa Prezzemolo1,2, Krista E van Meijgaarden1, Kees L M C Franken1, Nadia Caccamo2, Francesco Dieli2, Tom H M Ottenhoff1, Simone A Joosten1.
Abstract
HLA-E presented antigens are interesting targets for vaccination given HLA-Es' essentially monomorphic nature. We have shown previously that Mycobacterium tuberculosis (Mtb) peptides are presented by HLA-E to CD8+ effector T cells, but the precise phenotype and functional capacity of these cells remains poorly characterized. We have developed and utilized in this study a new protocol combining HLA-E tetramer with intracellular staining for cytokines, transcription factors and cytotoxic molecules to characterize these cells in depth. We confirm in this study the significantly increased ex vivo frequency of Mtb-peptide/HLA-E-TM+ CD8+ T cells in the circulation of patients with active tuberculosis (TB). HLA-E restricted CD8+ T cells from TB patients produced more IL-13 than cells from controls or subjects with latent tuberculosis infection (LTBI). Compared to total CD8+ T cells, HLA-E restricted cells produced more IFNγ, IL-4, IL-10, and granulysin but less granzyme-A. Moreover, compared to "classical" Mtb specific HLA-A2 restricted CD8+ T cells, HLA-E restricted CD8+ T cells produced less TNFα and perforin, but more IL-4. In conclusion, HLA-E restricted- Mtb specific cells can produce Th2 cytokines directly.Entities:
Keywords: Active TB; CD8+ T cells; Cytokines; Tetramers; Th2
Mesh:
Substances:
Year: 2017 PMID: 29124751 PMCID: PMC6266868 DOI: 10.1002/eji.201747184
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532